How to Buy Argenx Se Stock

Open Broker Account

Argenx Se

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France.

Argenx Se stock last closed at $393.26, down 2.25% from the previous day, and has increased 40.97% in one year. It has overperformed other stocks in the Biotechnology industry by 0.73 percentage points. Argenx Se stock is currently +57.62% from its 52-week low of $249.50, and -3.6% from its 52-week high of $407.93.

As of Dec 5, 2022, there are 55.06M ARGX shares outstanding. The market capitalization of ARGX is $21.65B. In the last 24 hours, 228,010 ARGX shares were traded.

How to Buy Argenx Se Stock

Wondering how to invest in Argenx Se stock? Here's how.
  1. Figure out where to buy Argenx Se stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Argenx Se stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected. It's the best place to buy ARGX stock.
  3. Deposit funds into your investment account: Select your payment method and add your details.
  4. Research Argenx Se stock: The Argenx Se ticker symbol is ARGX. Is Argenx Se stock a good investment? Should you buy shares of ARGX? How do ARGX's underlying business fundamentals look? Do top analysts think Argenx Se is a good buy? Why has ARGX's stock price moved recently? (Hint: Our stock research website can help you understand if ARGX is a good stock to buy).
  5. Execute your ARGX trade: Decide if you will purchase ARGX shares at the current market price or use a limit order to buy ARGX stock at a particular price.
  6. Monitor your investment in ARGX: Create a watchlist to keep tabs on your new investment in Argenx Se stock.

Step 1: Figure out where to buy Argenx Se stock

You need an online brokerage account in order to access the NASDAQ market and buy ARGX stock.

A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world financial markets: From Technology to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by creating an account with eToro now.

Open eToro Account

Step 2: Create your brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to buy ARGX stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
  2. Enter your personal data to open a new trading account.
  1. Submit your details by hitting the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your investment account

Watch this video walkthrough for more details depositing money into your brokerage account.

Get started with eToro today

Step 4: Research Argenx Se stock

It's critical to analyze stocks prior to buying, so you truly comprehend the risk and opportunity.

Argenx Se shares data

ARGX Price
1w %
1y %
5y %
Fore. Rev. Growth
Fore. Earn. Growth
Market Cap
Next Earnings
Next Dividend

Argenx Se Overview

WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on ARGX's stock page.

Is ARGX stock properly valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge ARGX's intrinsic value.

Using relative valuations ratios:

  • ARGX could be overvalued based on its P/B ratio of 7.22x, relative to Biotechnology industry P/B ratio of 4.96x

You can do additional valuation research on ARGX's stock here.

A look at ARGX Cashflows and Balance Sheet


  • ARGX has $2.62B in cash and short term investments. This is sufficient to cover its annual cash burn of $874.41M.
  • ARGX has cash burn of 874414141. It has sufficient cash and short-term investments to cover this for at least one year.
  • ARGX has a low debt to equity ratio of 0.09.
  • Total ARGX debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than short-term liabilities on the ARGX balance sheet.
  • There are more short-term assets than long-term liabilities on the ARGX balance sheet.


  • ARGX profit margin has gone down from -65.4% to -3,077% in the past year.

Is ARGX stock a Buy, Hold, or Sell?

Out of 13 sell side analysts who monitor ARGX, the consensus analyst rating on ARGX is a Strong Buy

Should I buy or sell ARGX stock?

Based on 13 analysts offering ratings for Argenx Se.
Strong Buy
Strong Buy
7 analysts 53.85%
3 analysts 23.08%
3 analysts 23.08%
0 analysts 0%
Strong Sell
0 analysts 0%

Latest ARGX Analyst Upgrades/Downgrades

Matthew Harrison, a bottom 3% analyst from Morgan Stanley maintains ARGX with a strong buy rating and raises their ARGX price target from $401.00 to $450.00, on Oct 28, 2022.

Joon Lee, a bottom 14% analyst from Truist Securities maintains ARGX with a strong buy rating and raises their ARGX price target from $410.00 to $420.00, on Oct 28, 2022.

Douglas Tsao, a top 21% analyst from HC Wainwright & Co. maintains ARGX with a buy rating and raises their ARGX price target from $425.00 to $440.00, on Oct 28, 2022.

Thomas Smith, a bottom 5% analyst from SVB Leerink maintains ARGX with a buy rating and raises their ARGX price target from $428.00 to $430.00, on Oct 28, 2022.

Derek Archila, a top 4% analyst from Wells Fargo maintains ARGX with a strong buy rating and raises their ARGX price target from $461.00 to $469.00, on Oct 18, 2022.

Archila bumped up his price target on Argenx SE by 1.7%.

The company will likely post "solid growth" for Q3 and Q4 2022, the analyst told investors, citing a survey on physicians who prescribe Vyvgart*.

The recent weakness in the shares following Symphony data** suggesting a decline in Vyvgart sales in 2022/09 "offers a nice setup" for the Q3 earnings report, Archila said.

Explaining his bullish thesis, the analyst contended that the data likely does not accurately reflect Vyvgart volumes.

Argenx "should at least meet, but more likely beat consensus," Archila argued, citing his "bullish responses" from his own survey.

* From here: Efgartigimod alfa, sold under the brand name Vyvgart, is a medication used to treat myasthenia gravis.

** From here: Symphony Data is a health care and insurance administrative outsourcing and information management services provider.

You can dig deeper into what analysts are forecasting on the Argenx Se stock forecast page.

ARGX Momentum

MACD Signal
MACD Histogram
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D

How is ARGX performing as a company?

Last year, ARGX revenue was $29.79M. Over the last five year, ARGX's revenue has increased by -2.92% per year. This was slower than the Biotechnology industry average of 80.69%.

Dig into ARGX's earnings and revenue performance here.

What are ARGX insiders up to?

In the past 12 months, executives and large shareholders at ARGX have not bought or sold any shares.

Learn more about who owns ARGX shares here.

Does ARGX provide a stable income stream?

No, Argenx Se doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Execute your ARGX trade

You have two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a specific dollar amount, place a limit order.

Click the Open Trade button and your broker will execute the order.

If you require more info about investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Monitor your investment in ARGX

Now that you own some shares in ARGX, you'll want to keep up with your new stock purchase.

Make a watchlist to get alerted to the latest events about your ARGX stock.


How to Buy Stock in Argenx Se

To summarize, here are the 6 steps to buy Argenx Se stock:

  1. Figure out where to buy Argenx Se stock
  2. Create your brokerage account
  3. Deposit funds into your investment account
  4. Research Argenx Se stock
  5. Execute your ARGX trade
  6. Monitor your investment in ARGX

If you need a brokerage, eToro is our favorite venue.

Get Started with eToro Today

If you want to get updates on your investment in Argenx Se, create a watchlist on WallStreetZen today.

$393.26-9.05 (-2.25%)
Updated Dec 5, 2022
Open eToro Account
$393.26-9.05 (-2.25%)
Updated Dec 5, 2022
Open eToro Account


How much does it cost to buy one Argenx Se share?

As of Dec 5, 2022, it costs $393.26 to buy one share of Argenx Se stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.254 shares of ARGX.

Get Started with eToro Today

Is now a good time to buy Argenx Se stock?

According to 13 Wall Street analysts who monitor Argenx Se, their consensus recommendation is to buy Argenx Se stock.

What is the best way to buy Argenx Se stock?

The best way to buy Argenx Se stock is within a brokerage account on eToro.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.